Answers are grounded in this paper and cite their sources.
Animal study demonstrates that SHANK3 mutations impair muscle and neuromuscular maturation in mice, indicating therapeutic potential for troponin activators in autism.
mice could be rescued with the troponin activator Tirasemtiv that sensitizes muscle fibers to calcium. Our observations give insight into the function of SHANK3 besides the central nervous system and imply potential treatment strategies for SHANK3-associated ASD.
No takes yet. Share an insight, caveat, or question.
Lutz et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: